Advances in Sickle Cell Disease Treatment: from Drug Discovery Until the Patient Monitoring

Publisher： Bentham Science Publishers

E-ISSN： 1875-6182|9|2|113-127

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.9, Iss.2, 2011-04, pp. : 113-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tailoring Treatment to the Individual Patient: Drug Monitoring

By  

Digestive Diseases, Vol. 32, Iss. 1, 2014-12 ,pp. : 88-91

Karger

Access to resources Recommend Favorite

Pulmonary Hypertension Associated with Sickle Cell Disease: Pathophysiology and Rationale for Treatment

By Benza Raymond  

Lung, Vol. 186, Iss. 4, 2008-08 ,pp. : 247-254

Springer Publishing Company

Access to resources Recommend Favorite

Safety And Efficacy Of 4 Years Of Deferasirox Treatment For Sickle Cell Disease Patients

By Vlachaki Efthymia  

Hemoglobin, Vol. 37, Iss. 1, 2013-02 ,pp. : 94-100

Informa Healthcare

Access to resources Recommend Favorite

Liver Cirrhosis in a Patient with Sickle Cell Trait (Hb Sβ+ Thalassemia) without Other Known Causes of Hepatic Disease

By  

Case Reports in Gastroenterology, Vol. 3, Iss. 3, 2009-09 ,pp. : 275-279

Karger

Access to resources Recommend Favorite

Small Bowel Ischemia in a Sickle Cell Patient

By  

Case Reports in Gastroenterology, Vol. 3, Iss. 1, 2009-03 ,pp. : 26-29

Karger

Access to resources Recommend Favorite